一次性内窥镜技术
Search documents
明智科技股份有限公司(H0386) - 申请版本(第一次呈交)
2026-01-29 16:00
香港聯合交易所有限公司與證券及期貨事務監察委員會對本申請版本的內容概不負責,對其準確性 或完整性亦不發表任何意見,並明確表示概不就因本申請版本全部或任何部分內容而產生或因倚賴 該等內容而引致的任何損失承擔任何責任。 本文件為草擬本,其所載資料並不完整及可作更改。閱讀本文件有關資料時,必須一併細閱本文件首頁「警告」一節。 警 告 本申請版本乃根據香港聯合交易所有限公司(「聯交所」)與證券及期貨事務監察委員會(「證監會」)的 要求而刊發,僅用作提供資料予香港公眾人士。 本 申 請 版 本 為 草 擬 本,其 內 所 載 資 料 並 不 完 整,亦 可 能 會 作 出 重 大 變 動。 閣 下 閱 覽 本 文 件,即 代 表 閣下知悉、接納並向本公司、本公司的獨家保薦人、整體協調人、顧問或包銷團成員表示同意: 倘於適當時候向香港公眾人士提出要約或邀請,有意投資者務請僅依據與香港公司註冊處處長註冊 的本公司招股章程作出投資決定;招股章程的文本將於發售期內向公眾人士刊發。 (a) 本文件僅為向香港公眾人士提供有關本公司的資料,概無任何其他目的;投資者不應根據本 文件所載資料作出任何投資決定; (b) 在聯交所網站登載本 ...
医用内窥镜应用日益广泛,欧菲光攻克一次性内窥镜核心技术难题
Xin Lang Cai Jing· 2025-07-15 01:28
Group 1: Market Overview - The global medical endoscope market is projected to reach $26.6 billion by 2024, with a CAGR of approximately 6.24% from 2017 to 2024 [1] - The United States is the largest market for medical endoscopes, followed by the European Union and China, with China expected to become the second-largest market and achieve the highest growth rate in the coming years [1] - The demand for single-use endoscopes is increasing due to their ability to significantly reduce infection risks, especially in fields with high infection control requirements such as urology, respiratory, and digestive departments [1] Group 2: Company Developments - OFILM has successfully overcome core technical challenges related to single-use endoscopes by 2025, achieving key performance breakthroughs and breaking international monopolies with high performance and cost advantages [2] - The company's endoscope products feature significant advantages such as miniaturization, stable modulation transfer function (MTF), high clarity, lightweight, waterproof, large depth of field, ultra-wide angle, and ultra-micro distance [2] - OFILM employs "integrated glue injection technology" and "high-precision wire bonding technology" to enhance the sealing of camera modules and stability of circuits, reducing signal transmission delay by 30% and achieving industry-leading imaging clarity [2] Group 3: Production and Future Plans - OFILM's urological system endoscope modules achieved mass production in April this year, with plans for large-scale production of digestive and respiratory system endoscope modules in the second half of the year [3] - The company aims to become the first Chinese manufacturer to supply a full range of endoscope modules globally, with a phased implementation plan for various types of endoscopes [3] - As the global healthcare industry continues to develop, single-use endoscopes are expected to find applications in more fields, indicating a broad market outlook [3]